Latest Pantoprazole Stories
CHAPEL HILL, N.C., Feb. 14, 2011 /PRNewswire/ -- Thought Leader Select, a Research Triangle, NC firm focused on collaborations between the biopharmaceutical industry and the medical community, announces the launch of a new media partnership with biopharmaceutical industry blog Marketing4Health.
MORRISTOWN, N.J., Feb. 8, 2011 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Pantoprazole Sodium Delayed-Release Tablets, USP.
PITTSBURGH, Jan. 24, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S.
ZURICH, July 19, 2010 /PRNewswire/ -- - Nycomed's Protonix(R) Patent Found Infringed and not Obvious - U.S.
Labeling changes will include new safety information SILVER SPRING, Md., May 25 /PRNewswire-USNewswire/ -- The U.S.
U.S. researchers suggest doctors may wish to limit acid reducer use for their ventilator patients. The study, published in Chest, also recommends if an acid reducer is needed, less powerful ranitidine -- Zantac, which inhibits gastric acid secretion -- be used.
A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold.
The US Justice Department announced on Monday that it would work alongside 16 states in two whistleblower lawsuits against Madison, NJ-based drugmaker Wyeth.
- totally perplexed and mixed up.